The Walter and Eliza Hall Institute of Medical Research
Victoria, Australia
Purpose
to develop a synthetic saccharide-conjugated vaccine that would provide immunity against GPI, a toxin produced by the malaria parasite that is a major determinant in the severity and fatality of the disease.
Division
Global Health
Date
May 2009
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
12
Grantee location
Victoria, Australia
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.